1 |
News |
text |
2 |
Features |
text |
3 |
Magazine |
text |
4 |
Advisory Board |
text |
5 |
Archive |
text |
6 |
Subscribe |
text |
7 |
Topics |
text |
8 |
Acute Coronary Syndrome |
text |
9 |
Cardiovascular Imaging |
text |
10 |
Coronary Intervention & Surgery |
text |
11 |
Electrophysiology & Arrhythmia |
text |
12 |
Healthcare Economics & Policy |
text |
13 |
Heart Failure |
text |
14 |
Hypertension |
text |
15 |
Lipids & Metabolic |
text |
16 |
Practice Management |
text |
17 |
Structural & Congenital Heart Disease |
text |
18 |
Vascular & Endovascular |
text |
19 |
Conferences |
text |
20 |
Resources |
text |
21 |
Case Studies |
text |
22 |
Press Releases |
text |
23 |
Videos & Webinars |
text |
24 |
Whitepapers |
text |
25 |
Subscribe |
text |
26 |
- |
empty |
27 |
78% of COVID-19 patients show signs of heart damage after recovery |
text |
28 |
Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues |
text |
29 |
MLB player’s myocarditis puts spotlight on potential cardiovascular complications of COVID-19 |
text |
30 |
Cardiology one of healthcare’s top specialties when it comes to net worth, paying off debt |
text |
31 |
Treating COVID-19 with hydroxychloroquine, with or without azithromycin, leads to more deaths |
text |
32 |
- |
image |
33 |
Updated cardiac imaging recommendations for treating COVID-19 patients |
text |
34 |
Cardiologist recalls role in getting LA police to stop using chokeholds, connects experience with current events |
text |
35 |
CV societies ‘very concerned’ about proposed coverage changes for MR therapy |
text |
36 |
Evoloc***ab use benefits people living with HIV, dyslipidemia patients |
text |
37 |
Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues |
text |
38 |
Even with EHRs, tracking performance scores related to cardiovascular health remains a challenge |
text |
39 |
How social distancing, outdoor temperatures impact the spread of COVID-19 |
text |
40 |
FROM THE MAGAZINE |
text |
41 |
New Data Underscore Importance of Looking for HCM Before Scheduling TAVR |
text |
42 |
FROM THE MAGAZINE |
text |
43 |
Acute Coronary Syndrome |
text |
44 |
- |
image |
45 |
What new research out of Korea tells us about NSAID use and heart attacks |
text |
46 |
Engineers unveil new self-powered heart monitor made with polyvinyl alcohol |
text |
47 |
Adding aliroc***ab to high-intensity statin therapy benefits older ACS patients |
text |
48 |
Unnecessary care: Levothyroxine ineffective for heart attack patients with subclinical hypothyroidism |
text |
49 |
New antiplatelet drug could be a breakthrough for heart attack patients |
text |
50 |
MORE » |
text |